Skip to content

Vor Biopharma VOR Occupancy and Related Charges

Occupancy and Related Charges at other companies

TMC the metals company Inc. logo
TMC the metals company Inc.TMC
$477K0.0%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$200K+100%
EOG Resources logo
EOG ResourcesEOG
$462M+15.2%
The Bancorp logo
The BancorpTBBK
$1.28M-5.6%
Digital Realty logo
Digital RealtyDLR
$694.13M+13.7%
FAN
Diamondback EnergyFANG
$547M+34.1%

Other financials

Income statement

See full
Operating income-$35.2M-5.6%
Net income-$219.6M-576%
EPS (diluted)-$5.11+1.9%

Balance sheet

See full
Cash & equivalents$169.9M+239%
Total debt$2.9M-90.5%
Total equity-$150.4M-328%
Total assets$506.7M+364%

Cash flow

See full
Operating cash flow-$38.2M-23.1%
CapEx$48.0K-79.2%
Free cash flow-$38.3M-22.4%

Valuation

See full
Market cap$784.61M+2,594%
Enterprise value$617.68M+5,866%

Returns & leverage

See full
Return on equity-125.4%+671pp
Debt / equity0.5×+0.2×
Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseExpense.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's occupancy and related charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vor Biopharma's occupancy and related charges?
Vor Biopharma (VOR) reported occupancy and related charges of $109K in Q1 2026.
How has Vor Biopharma's occupancy and related charges changed year-over-year?
Vor Biopharma's occupancy and related charges decreased by 91.7% year-over-year, from $1.31M to $109K.
What is the long-term trend for Vor Biopharma's occupancy and related charges?
Over 4 years (2021 to 2025), Vor Biopharma's occupancy and related charges has grown at a 17.0% compound annual growth rate (CAGR), from $3.02M to $5.65M.
What does occupancy and related charges mean?
This represents the non-cash expense recognized for the use of leased assets over the lease term. It reflects the company's ongoing commitment to facility or equipment rentals necessary for clinical operations.